3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
105
Leukemia
65
Burkitt Lymphoma
26
Lymphoma
18
Leukemia, Biphenotypic, Acute
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia, Promyelocytic, Acute
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasm, Residual
5
Leukemia, Myeloid, Acute
5
Down Syndrome
4
Neoplasms
3
Leukemia, T-Cell
3
Dendritic Cell Sarcoma, Interdigitating
3
Neoplasm Metastasis
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Glioblastoma
2
Thrombocytopenia
1
Rare Diseases
1
Philadelphia Chromosome
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neutropenia
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Mucositis
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Interventions
Doxorubicin
15
Exercise
9
Cyclophosphamide
9
Dexrazoxane
8
Razoxane
6
Carvedilol
6
Vincristine
4
Trastuzumab
4
Radiotherapy
4
Filgrastim
4
Docetaxel
4
Methotrexate
3
Granulocyte Colony-Stimulating Factor
3
Etoposide
3
Echocardiography
3
Atorvastatin
3
salicylhydroxamic acid
2
sacubitril and valsartan sodium hydrate drug combination
2
empagliflozin
2
dapagliflozin
2
Tablets
2
Silymarin
2
Prednisone
2
Paclitaxel
2
Neoadjuvant Therapy
2
Leucovorin
2
Ivabradine
2
High-Intensity Interval Training
2
Epirubicin
2
Electrocardiography
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Cardiotoxicity
×
Mercaptopurine
×
Clear all
NCT01230983
2013-06-06
T-Cell #4
Children's Oncology Group
Phase 3
Completed
573 enrolled